Anthrax Vaccine Immunization Program
... [2] [3] , despite the fact that the Food and
drug Administration (FDA) issued a warning letter to ... approved by the government, despite the Food and
drug Administration issuing its “final rule” on the ... Department of Health and Human Services, Food and
drug Administration.
Docket No. 1980N-0208 ...
Medical procedure
... Immunosuppressive therapy
Psychotherapy
drug therapy
Acupuncture
Antivenom
... Contraindication
Complication (medicine)
drug interaction
Iatrogenesis
Medical error
Medical prescription
Nocebo
Responsible
drug use
Vital signs
Consensus (medical)
...
Medical writing
... include monographs about a newly launched
drug for sales representatives, data presentations at ... has its own medical writers who work on the
drug products developed by that company. Outsourced ... writers to draft documents involving their
drug products. The external professional medical ...
Personalized medicine
... are opening the possibility of a new approach to
drug development as well as unleashing the potential ... large based on what is known as the ' blockbuster
drug model'. A blockbuster
drug is a product capable of achieving sales of over ...
Artecoll
...
2 Potential risks and side effects
3 U.S. Food and
drug Administration approval
4 References
5 External links
... and can be difficult for doctors to treat. [2]
U.S. Food and
drug Administration approval
Before Artecoll was approved by the U.S. FDA, ...
Somatic dysfunction
... in November of 1999, researchers concluded that OMM and traditional
drug therapy resulted in equivalent resolution of lower back pain in a nearly ... intervention. The advantage of OMM was diminution of adverse
drug reactions while the disadvantage was the greater amount of physician time ...
Surrogate markers
... used example is cholesterol . A clinical trial may show that a particular
drug is effective in reducing cholesterol. A high cholesterol is associated ... CD, et al. (1999). "Surrogate end points, health outcomes, and the
drug approval process for the treatment of risk factors for cardiovascular ...
Dose concentration
... Dose concentration is the measure of the ratio of the mass of the
drug to the volume that contains it, often measured in units of moles /m 3 . ...
Gastric lavage
... years as a means of eliminating poisons from the stomach. Such devices are normally used on a person who has ingested a poison or overdosed on a
drug . They may also be used prior to surgery , to clear the contents of the digestive tract before it is opened.
Contents
1 ...
Hy's Law
... Hy's law is prognostic indicator that a pure
drug -Induced Liver Injury (DILI) leading to jaundice, without a hepatic transplant , has a case fatality rate of 10% to 50%. The law is based on ...
Medicine
... healthcare providers. One problem with this 'best practice' approach is that it could be seen to stifle novel approaches to treatment.
drug ampoules
Genomics and knowledge of human genetics is already having some influence on medicine, as the causative genes of most monogenic ...
NeuroArm
... and nursing management." [3]
"Tests will be conducted on mannequins, cadavers and tissues to prove to Health Canada and the U.S. Food and
drug Administration that it is safe for people. Officials hope neuroArm will be used to treat its first patient this summer [2007]." [1]
...
Sexual orientation and medicine
... [8]
2007
The American Medical Student Association membership votes to create an action committee on LGBT health issues.
The US Food and
drug Administration re-affirms its policy prohibiting men who have sex with men (MSM) from donating blood despite recommendations from the American ...